715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials

Authors :: Victor Cervera-Carrascon
Inge Svane
Katriina Peltola
Tuomo Alanko
Riitta Korpisaari
Susanna Juteau
Marjut Jaakkola
Jorma Sormunen
Juha Kononen
Eva Ellebaek Steensgaard
Tine Monberg
Marco Donia
Amir Khammari
Brigitte Dreno
Joao Santos
Suvi Sorsa
Riikka Havunen
Akseli Hemminki
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools